Kevin D. Freeman - 23 Sep 2021 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
/s/ Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
23 Sep 2021
Net transactions value
+$11,631
Form type
4
Filing time
23 Sep 2021, 16:14:52 UTC
Next filing
19 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $11,631 +3,000 +10% $3.88 33,000 23 Sep 2021 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings, LLC F1
holding GALT Common Stock 23,469 23 Sep 2021 Direct
holding GALT Common Stock 16,000 23 Sep 2021 IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.